This presentation discusses the integration of Quality by Design (QbD) principles to improve quality within the pharmaceutical manufacturing process, providing insights into effective implementation strategies. The discussion advocates for the adoption of risk-based approaches to identify and address potential issues, emphasizing a focus on critical processes and regulatory compliance. A proactive culture of continuous improvement is explored, showcasing the utilization of digital tools to optimize processes and elevate overall quality management. The presentation concludes by highlighting the importance of establishing a proactive approach to regulatory compliance, underlining the significance of thorough documentation and regular self-assessments. In this session, you will learn more about

• Different applications of Quality by Design (QbD) principles in designing quality manufacturing processes
• How to adopt risk-based approaches for identifying and mitigating potential issues in critical processes
• How to cultivate a culture of continuous improvement through digital tools and maintaining proactive regulatory compliance practices.